hippuric acid has been researched along with Prostatic Hyperplasia in 1 studies
hippuric acid: RN given refers to parent cpd; structure in Merck Index, 9th ed, #4591
N-benzoylglycine : An N-acylglycine in which the acyl group is specified as benzoyl.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, J | 1 |
| Han, Z | 1 |
| Luo, W | 1 |
| Shen, J | 1 |
| Xie, F | 1 |
| Liao, L | 1 |
| Zou, G | 1 |
| Luo, X | 1 |
| Guo, Z | 1 |
| Li, Y | 1 |
| Li, J | 1 |
| Chen, H | 1 |
1 other study available for hippuric acid and Prostatic Hyperplasia
| Article | Year |
|---|---|
Serum organic acid metabolites can be used as potential biomarkers to identify prostatitis, benign prostatic hyperplasia, and prostate cancer.
Topics: Biomarkers; Humans; Male; Meglutol; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neop | 2022 |